The expression and effect of IL-18 after hypoxic-ischemic brain damage
Chu Gui-lan
Abstract
Chu Gui-lan
Abstract
Objective To explore the expression and effect of interleukin(IL)-18 after hypoxic-ischemic brain damage(HIBD) in neonatal rats. Methods The HIBD model of seven-day-old Wistar rats was established. The mRNA and protein for IL-18 in cerebral cortex of control group, HIBD3 h, 8 h, 24 h, 3 d, 6 d and 14 d group were analyzed by RT-PCR and immunohistochemistry respectively, at the same time histological changes were observed. Results The expression of IL-18 mRNA and protein was low in control group[mRNA: 0.321 8±0.046 6; protein: (6.033± 1.019)cells/field]. After HIBD, the level of mRNA/protein for IL-18 in ischemic cortex increased progressively at 24 h to 6 d [mRNA: 24 h: 0.582 3±0.074 0, 3 d:0.697 6 ±0.107 3, 6 d: 0.911 0±0.064 7; protein: 24 h: (19.133±2.094)cells/field, 3 d: (28.900 ±1.589) cells/field, 6 d: (52.883±3.203)cells/field; P0.01 vs control], and reached its greatest level at 6 d (P0.01 vs other groups). The mRNA/protein for IL-18 decreased significantly at 14 d of reperfusion[mRNA: 0.579 3±0.084 2; protein:(16.767±2.381)cells/field], but was still higher than the normal level(P 0.01 vs control). Histological study showed that the degenerated and necrotic neurons increased progressively at 1 d to 6 d after HIBD, at the same time the proliferation of glial cells appeared. Conclusion The increasing expression of IL-18 mRNA/protein after HIBD was delayed and lasting, which implied that it may play an important role in late-stage inflammatory responses to HIBD in neonatal rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the expression and effect of interleukin(IL)-18 after hypoxic-ischemic brain damage(HIBD) in neonatal rats. Methods The HIBD model of seven-day-old Wistar rats was established. The mRNA and protein for IL-18 in cerebral cortex of control group, HIBD3 h, 8 h, 24 h, 3 d, 6 d and 14 d group were analyzed by RT-PCR and immunohistochemistry respectively, at the same time histological changes were observed. Results The expression of IL-18 mRNA and protein was low in control group[mRNA: 0.321 8±0.046 6; protein: (6.033± 1.019)cells/field]. After HIBD, the level of mRNA/protein for IL-18 in ischemic cortex increased progressively at 24 h to 6 d [mRNA: 24 h: 0.582 3±0.074 0, 3 d:0.697 6 ±0.107 3, 6 d: 0.911 0±0.064 7; protein: 24 h: (19.133±2.094)cells/field, 3 d: (28.900 ±1.589) cells/field, 6 d: (52.883±3.203)cells/field; P0.01 vs control], and reached its greatest level at 6 d (P0.01 vs other groups). The mRNA/protein for IL-18 decreased significantly at 14 d of reperfusion[mRNA: 0.579 3±0.084 2; protein:(16.767±2.381)cells/field], but was still higher than the normal level(P 0.01 vs control). Histological study showed that the degenerated and necrotic neurons increased progressively at 1 d to 6 d after HIBD, at the same time the proliferation of glial cells appeared. Conclusion The increasing expression of IL-18 mRNA/protein after HIBD was delayed and lasting, which implied that it may play an important role in late-stage inflammatory responses to HIBD in neonatal rats.
Key concepts: Messenger RNA, Brain damage, Immunohistochemistry, Cerebral cortex, Molecular biology, Andrology, Internal medicine, Biology